Team:METU Turkey safety
From 2014.igem.org
Ilkem.kumru (Talk | contribs) |
|||
(5 intermediate revisions not shown) | |||
Line 15: | Line 15: | ||
<table id="menu" width="100%" cellspacing="0" height="40px"> | <table id="menu" width="100%" cellspacing="0" height="40px"> | ||
<tr> | <tr> | ||
- | |||
- | |||
- | |||
<table align="center"> | <table align="center"> | ||
Line 35: | Line 32: | ||
<td width="162px" align="center" onMouseOver="this.bgColor='#FEE5AD'" onMouseOut="this.bgColor='#A1DBB2'" bgColor=#A1DBB2> | <td width="162px" align="center" onMouseOver="this.bgColor='#FEE5AD'" onMouseOut="this.bgColor='#A1DBB2'" bgColor=#A1DBB2> | ||
<a href="https://2014.igem.org/Team:METU_Turkey_modeling" style="text-decoration:none;color:#1C140D">MODELING </a> </td> | <a href="https://2014.igem.org/Team:METU_Turkey_modeling" style="text-decoration:none;color:#1C140D">MODELING </a> </td> | ||
- | + | ||
- | + | ||
<td width="162px" align="center" onMouseOver="this.bgColor='#FEE5AD'" onMouseOut="this.bgColor='#A1DBB2'" bgColor=#A1DBB2> | <td width="162px" align="center" onMouseOver="this.bgColor='#FEE5AD'" onMouseOut="this.bgColor='#A1DBB2'" bgColor=#A1DBB2> | ||
<a href="https://2014.igem.org/Team:METU_Turkey_interlabstudy" style="text-decoration:none;color:#1C140D">INTERLAB STUDY </a></td> | <a href="https://2014.igem.org/Team:METU_Turkey_interlabstudy" style="text-decoration:none;color:#1C140D">INTERLAB STUDY </a></td> | ||
+ | |||
+ | </tr> | ||
+ | <tr height="50px"> | ||
+ | |||
<td width="162px" align="center" onMouseOver="this.bgColor='#FEE5AD'" onMouseOut="this.bgColor='#A1DBB2'" bgColor=#A1DBB2> | <td width="162px" align="center" onMouseOver="this.bgColor='#FEE5AD'" onMouseOut="this.bgColor='#A1DBB2'" bgColor=#A1DBB2> | ||
Line 53: | Line 53: | ||
<td width="162px" align="center" onMouseOver="this.bgColor='#FEE5AD'" onMouseOut="this.bgColor='#A1DBB2'" bgColor=#A1DBB2> | <td width="162px" align="center" onMouseOver="this.bgColor='#FEE5AD'" onMouseOut="this.bgColor='#A1DBB2'" bgColor=#A1DBB2> | ||
<a href="https://2014.igem.org/Team:METU_Turkey_attributions" style="text-decoration:none;color:#1C140D">ATTRIBUTIONS </a></td> | <a href="https://2014.igem.org/Team:METU_Turkey_attributions" style="text-decoration:none;color:#1C140D">ATTRIBUTIONS </a></td> | ||
+ | |||
+ | <td width="162px" align="center" onMouseOver="this.bgColor='#FEE5AD'" onMouseOut="this.bgColor='#A1DBB2'" bgColor=#A1DBB2> | ||
+ | <a href="https://2014.igem.org/Team:METU_Turkey_gallery" style="text-decoration:none;color:#1C140D">GALLERY </a></td> | ||
+ | |||
+ | <td width="162px" align="center" onMouseOver="this.bgColor='#FEE5AD'" onMouseOut="this.bgColor='#A1DBB2'" bgColor=#A1DBB2> | ||
+ | <a href="https://2014.igem.org/Team:METU_Turkey_protocols" style="text-decoration:none;color:#1C140D">PROTOCOLS </a></td> | ||
</tr> | </tr> | ||
</table> | </table> | ||
</td> | </td> | ||
- | |||
</tr> | </tr> | ||
</table> | </table> | ||
Line 69: | Line 74: | ||
</table> | </table> | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
<!-- Block of content 1 --> | <!-- Block of content 1 --> | ||
<table width="100%" cellspacing="0" height="500px"> | <table width="100%" cellspacing="0" height="500px"> | ||
Line 121: | Line 97: | ||
<!-- This is the back to top button --> | <!-- This is the back to top button --> | ||
- | |||
- | |||
</table> | </table> | ||
Line 156: | Line 130: | ||
<h3>2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues?</h3> | <h3>2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues?</h3> | ||
<p>We have followed all the safety procedures during the isolation process from the cells we had and we successfully isolated the DNA without any problems that will raise safety issues.</p> | <p>We have followed all the safety procedures during the isolation process from the cells we had and we successfully isolated the DNA without any problems that will raise safety issues.</p> | ||
- | <h3>3.Is there a local biosafety group, committee, or review board at your institution? | + | <h3>3.Is there a local biosafety group, committee, or review board at your institution? |
- | + | If yes, what does your local biosafety group think about your project? | |
- | If no, which specific biosafety rules or guidelines do you have to consider in your country? | + | If no, which specific biosafety rules or guidelines do you have to consider in your country?</h3> |
- | In our university we have a biosafety and ethical research center which monitors the safety of our projects. http://www.ueam.metu.edu.tr The members of METU Biology department are also members of National Biosafety Coordinating Committee. We are able to consult to them whenever it is necessary. Also biosafety is a very important subject for METU Department of Biology, whereas the student members are very well trained in the subject. Also the projects that we decided to work on are presented to many people in the area in order to see if they are of any concern for the biosafety regulations. All the procedures that are used in the lab are also approved procedures that are used by these people mentioned above.</p> | + | <p>In our university we have a biosafety and ethical research center which monitors the safety of our projects. http://www.ueam.metu.edu.tr The members of METU Biology department are also members of National Biosafety Coordinating Committee. We are able to consult to them whenever it is necessary. Also biosafety is a very important subject for METU Department of Biology, whereas the student members are very well trained in the subject. Also the projects that we decided to work on are presented to many people in the area in order to see if they are of any concern for the biosafety regulations. All the procedures that are used in the lab are also approved procedures that are used by these people mentioned above.</p> |
<h3>4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?</h3> | <h3>4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?</h3> | ||
We believe using specific strains designed specifically for labwork will be safer. It is possible to genetically modify the organisms so that, they are not able to grow outside the lab environment. There probably is not a way to build some biobricks that can be modified in order to make them safer since their function will be the cause of safety issues. </p> | We believe using specific strains designed specifically for labwork will be safer. It is possible to genetically modify the organisms so that, they are not able to grow outside the lab environment. There probably is not a way to build some biobricks that can be modified in order to make them safer since their function will be the cause of safety issues. </p> | ||
Line 177: | Line 151: | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
Line 231: | Line 161: | ||
</table> | </table> | ||
<!-- end of Block--> | <!-- end of Block--> | ||
- | |||
Line 244: | Line 173: | ||
<td align="center" width="162px"><a href="http://www.etietieti.com/"> <img src="https://static.igem.org/mediawiki/2014/7/75/Eti.jpg" width="175px"></a></td> | <td align="center" width="162px"><a href="http://www.etietieti.com/"> <img src="https://static.igem.org/mediawiki/2014/7/75/Eti.jpg" width="175px"></a></td> | ||
+ | |||
+ | <td align="center"><a href="http://www.taa-ankara.org.tr/eng/index-eng.php"> <img src="https://static.igem.org/mediawiki/2014/0/00/Turkamerikan.jpg" width="175px"></a></td> | ||
+ | |||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | |||
<td align="center"><a href="http://www.biyans.com/"> <img src="https://static.igem.org/mediawiki/2014/a/a3/Biyans.PNG" width="175px"></a></td> | <td align="center"><a href="http://www.biyans.com/"> <img src="https://static.igem.org/mediawiki/2014/a/a3/Biyans.PNG" width="175px"></a></td> | ||
<td align="center"><a href="http://biyoakademi.org/"> <img src="https://static.igem.org/mediawiki/2014/b/b1/Biyoakademi.png" width="175px"></a></td> | <td align="center"><a href="http://biyoakademi.org/"> <img src="https://static.igem.org/mediawiki/2014/b/b1/Biyoakademi.png" width="175px"></a></td> | ||
- | |||
- | |||
<td align="center"><a href="http://www.sentegen.com/"> <img src="https://static.igem.org/mediawiki/2014/d/dd/Sentegenlogoder.PNG" width="175px"></a></td> | <td align="center"><a href="http://www.sentegen.com/"> <img src="https://static.igem.org/mediawiki/2014/d/dd/Sentegenlogoder.PNG" width="175px"></a></td> | ||
- | |||
- | |||
<td align="center"><a href="http://www.geneious.com/"> <img src="https://static.igem.org/mediawiki/2014/8/89/Geneious_Logo.gif" width="175px"></a></td> | <td align="center"><a href="http://www.geneious.com/"> <img src="https://static.igem.org/mediawiki/2014/8/89/Geneious_Logo.gif" width="175px"></a></td> | ||
Line 280: | Line 207: | ||
</tr> | </tr> | ||
</table> | </table> | ||
- | |||
</html> | </html> |
Latest revision as of 01:14, 18 October 2014
Team:METU Turkey/Templates/Navigationbar
HOME | TEAM | PROJECT | PARTS | MODELING | INTERLAB STUDY |
POLICY&PRACTICE | CHARACTERIZATION | SAFETY | ATTRIBUTIONS | GALLERY | PROTOCOLS |
|
|
Our Supporter: | ||